Morningstar Says SpaceX Could Be Worth Less Than Half IPO
Morningstar analysts warn SpaceX could be worth far less than its IPO price, focusing on profitability gaps and Starl...
Discover which index funds are top rated for retirement in 2024 and why they matter for your portfolio. Learn about performance, fees, and diversification.
25,383 articlesMorningstar analysts warn SpaceX could be worth far less than its IPO price, focusing on profitability gaps and Starl...
UnitedHealth stock quietly soared about 80% off its 2025 low, signaling a meaningful rebound. This article dives into...
July 2026 offers a compelling setup for patient investors. Here’s my top-ranked stock for July, why it stands out, an...
As 2025 reshapes the housing market, first-time buyers gain access to more flexible programs and faster closings. Thi...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
Axon is set to report Q4 2025 results after the close, as Wall Street weighs software momentum, AI-era bookings, and ...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
Uber is moving away from the idea of a laid-back culture. CEO Dara Khosrowshahi asserts a relentless work ethic, even...
SpaceX faces a towering IPO target: a $1.5 trillion market cap. Analysts say the math hinges on unprecedented growth ...
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
Northrop Grumman has surged in 2026 on a record backlog and strong cash flow, but a major program in limbo keeps inve...
Powell Industries may fly under the radar, but patient investors can uncover a potential opportunity. This guide brea...